Sang Yoon Kim Selected Research

Aphonia

3/2022

Treatment Efficacy of Voice Therapy Following Injection Laryngoplasty for Unilateral Vocal Fold Paralysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sang Yoon Kim Research Topics

Disease

143	Neoplasms (Cancer) 07/2022 - 10/2003
41	Squamous Cell Carcinoma of Head and Neck 01/2021 - 04/2002
38	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2006
22	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 10/2003
16	Carcinoma (Carcinomatosis) 01/2019 - 11/2005
13	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 09/2006
11	Hypoxia (Hypoxemia) 01/2021 - 08/2005
11	Extranodal Extension 01/2020 - 04/2014
8	Papillary Thyroid Cancer 02/2022 - 04/2014
8	Breast Neoplasms (Breast Cancer) 11/2018 - 08/2005
7	Lymphatic Metastasis 01/2020 - 09/2012
6	Body Weight (Weight, Body) 01/2020 - 01/2013
6	Hypoalbuminemia 12/2018 - 06/2011
5	Hypopharyngeal Neoplasms 07/2022 - 01/2012
5	Deglutition Disorders (Dysphagia) 07/2022 - 08/2009
5	Carcinogenesis 01/2021 - 05/2005
5	Laryngeal Neoplasms (Laryngeal Cancer) 07/2018 - 06/2013
4	Salivary Gland Neoplasms (Salivary Gland Cancer) 05/2015 - 02/2007
4	Nasopharyngeal Carcinoma 05/2008 - 03/2005
3	Fistula 12/2022 - 10/2006
3	Inflammation (Inflammations) 05/2022 - 01/2002
3	Paralysis (Palsy) 03/2022 - 03/2002
3	Hypothyroidism 02/2022 - 12/2018
3	Myocardial Infarction 01/2020 - 10/2014
3	Margins of Excision 01/2020 - 01/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2017 - 11/2005
3	Necrosis 07/2017 - 10/2006
3	Hemorrhage 02/2017 - 05/2008
3	Prognathism 01/2016 - 12/2013
3	Lung Neoplasms (Lung Cancer) 03/2015 - 11/2005
3	Tongue Neoplasms (Tongue Neoplasm) 01/2015 - 01/2009
3	Melanoma (Melanoma, Malignant) 12/2009 - 02/2008
2	Thrombosis (Thrombus) 01/2022 - 06/2007
2	Triple Negative Breast Neoplasms 01/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

23	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2020 - 02/2007
20	Pharmaceutical PreparationsIBA 01/2022 - 05/2005
19	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2008
17	Heparin (Liquaemin)FDA LinkGeneric 09/2017 - 09/2006
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2005
10	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 09/2006
9	Caspase 3 (Caspase-3)IBA 01/2022 - 04/2013
9	ProdrugsIBA 01/2019 - 02/2015
9	Angiogenesis InhibitorsIBA 04/2016 - 12/2008
8	FluorineIBA 01/2020 - 04/2014
8	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2016 - 06/2009
7	Therapeutic UsesIBA 01/2016 - 02/2008
6	AlbuminsIBA 01/2022 - 01/2016
6	Peptides (Polypeptides)IBA 01/2022 - 11/2007
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 12/2009
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2007 - 04/2002
5	AnticoagulantsIBA 01/2021 - 06/2009
5	Deoxycholic Acid (Sodium Deoxycholate)IBA 10/2017 - 04/2007
5	Indicators and Reagents (Reagents)IBA 09/2017 - 02/2015
5	Taurocholic Acid (Sodium Taurocholate)IBA 04/2016 - 06/2012
4	Cytotoxins (Cytolysins)IBA 01/2022 - 07/2018
4	CaspasesIBA 10/2021 - 02/2011
4	Serum AlbuminIBA 12/2018 - 02/2016
4	PolymersIBA 10/2017 - 02/2007
4	Poloxamer (Poloxamer 407)IBA 10/2017 - 12/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 02/2012 - 04/2009
4	Desoxycorticosterone Acetate (DOCA)FDA Link 12/2010 - 09/2006
3	IntegrinsIBA 01/2022 - 11/2012
3	Messenger RNA (mRNA)IBA 01/2022 - 03/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2008
3	IodineIBA 10/2020 - 01/2015
3	Sirolimus (Rapamycin)FDA Link 01/2019 - 07/2013
3	LigandsIBA 01/2019 - 04/2014
3	DNA (Deoxyribonucleic Acid)IBA 07/2018 - 08/2005
3	Cyclin D1IBA 07/2017 - 08/2005
3	CateninsIBA 01/2016 - 04/2013
3	Docetaxel (Taxotere)FDA Link 10/2015 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 10/2015 - 03/2005
3	Celecoxib (Celebrex)FDA Link 07/2015 - 05/2005
3	dimethyl sulfone (methylsulfonylmethane)IBA 06/2015 - 01/2012
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2012 - 01/2009
3	Erythropoietin Receptors (Erythropoietin Receptor)IBA 10/2012 - 06/2008
3	Deoxyglucose (2 Deoxy D glucose)IBA 10/2012 - 04/2005
3	glycol-chitosanIBA 02/2012 - 10/2007
2	Retinaldehyde (Retinal)IBA 07/2022 - 01/2022
2	CytokinesIBA 01/2021 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 04/2014

Therapy/Procedure

58	Therapeutics 07/2022 - 03/2005
46	Radiotherapy 01/2022 - 03/2005
23	Neck Dissection (Radical Neck Dissection) 10/2020 - 02/2006
18	Chemoradiotherapy 01/2020 - 02/2011
17	Drug Therapy (Chemotherapy) 01/2022 - 02/2007
12	Aftercare (After-Treatment) 07/2022 - 02/2007
10	Thyroidectomy 10/2020 - 07/2007
6	Laryngectomy 01/2022 - 02/2006
6	Oral Administration 11/2017 - 05/2008
5	Tracheostomy 01/2022 - 01/2016
5	Salvage Therapy 09/2019 - 01/2016
4	Osteotomy 07/2014 - 12/2013
4	Microspheres (Microsphere) 08/2006 - 01/2002
3	Laryngoplasty 03/2022 - 03/2002
3	Injections 10/2017 - 08/2006
3	Induction Chemotherapy 10/2015 - 09/2011
3	Chemoprevention 02/2015 - 05/2005
2	Immunotherapy 01/2021 - 01/2019